Hormone therapy use associated with greater migraine burden in postmenopausal women
Migraines are estimated to affect 10% to 29% of women during the menopause transition, when migraines often worsen and become more frequent, especially during perimenopause. This is due to unpredictable estrogen drops. A new study suggests postmenopausal women using hormone therapy will experience more frequent, longer-lasting migraines. Results of the study were presented at the 2026 Annual…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Caregivers with heart disease face high psychological distress risks
United Kingdom
-
Why teaching AI about symmetry could make prenatal diagnosis more reliable
United Kingdom
-
Anxiety and depression linked to higher levels of pregnancy "brain fog"
United Kingdom
-
Preschool social-emotional lessons improve long-term adult well-being
United Kingdom
-
Scientists finally uncover why statins can cause muscle pain
United States
-
Texas Man Finds More Than $128,000 on Top of a Bank’s ATM–and Returns Every Dollar
United Kingdom
-
Potential tissue effects: Microablative fractional radiofrequency in postmenopausal women
United Kingdom
-
Immature brain support cells may be linked to human age-related cognitive decline
United Kingdom